Two views on HDCT-ABMT breast cancer treatment controversy. Too experimental for insurers--or just too expensive?

Autor:	R D, Carter, D M, Coleman, J E, Bennett
Rok vydání:	1991
Předmět:	Cost Control Drug Therapy Insurance Health Reimbursement Humans Insurance Carriers Breast Neoplasms Ethics Institutional Female Patient Advocacy Transplantation Autologous United States Bone Marrow Transplantation
Zdroj:	HealthSpan. 9(1)
ISSN:	0883-0452
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::4ea9ad4bd73112b05d93b081bbaaa165 https://pubmed.ncbi.nlm.nih.gov/10117134 Zobrazit plný text záznamu